跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,587 条关于
“Paroxysmal nocturnal hemoglobinuria”
全部
1,587
临床试验
1,358
药物
12
机构
1
资讯
216
11个月前
Chugai Launches PiaSky as Taiwan's First Subcutaneous Treatment for Paroxysmal Nocturnal Hemoglobinuria
去年
Taiwan Approves Chugai's PiaSky as First Subcutaneous Treatment for Paroxysmal Nocturnal Hemoglobinuria
去年
Ruxoprubart Achieves Primary Endpoints in Phase 2 Trial for Paroxysmal Nocturnal Hemoglobinuria
去年
Ruxoprubart Shows Promising Phase II Results as Novel Monotherapy for Paroxysmal Nocturnal Hemoglobinuria
去年
Paroxysmal Nocturnal Hemoglobinuria Pipeline Shows Robust Development with 25+ Therapies from Leading Pharmaceutical Companies
去年
Argo Biopharma Advances siRNA Therapy BW-40202 to Phase II Trial for Paroxysmal Nocturnal Hemoglobinuria
去年
Regeneron Highlights Hematology Pipeline Progress at ASH 2024
2年前
Novartis Highlights New Data on Kisqali, Iptacopan, and Scemblix at SABCS and ASH
去年
Sobi to Present New Hematology Data at ASH 2024, Highlighting Advances in Rare Blood Disorders
2年前
Long-term efficacy and safety of iptacopan in PNH with anaemia
第 1 页，共 22 页
上一页
下一页
